Biomarkers in advanced heart failure - Pathophysiology leading to clinical use?

Journal of Heart and Lung Transplantation

Volumn 33, Issue 12, 2014, Pages 1213-1214

  Lund, Lars H ^a,b   Gabrielsen, Anders ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; CATECHOLAMINE; COLLAGEN; CYSTATIN C; GALECTIN 3; GROWTH DIFFERENTIATION FACTOR; INTERLEUKIN 1BETA; MATRIX METALLOPROTEINASE; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; NORADRENALIN; TOLL LIKE RECEPTOR; LIPOCALIN; ONCOPROTEIN;

DISEASE SEVERITY; HEART FAILURE; HEART INFARCTION; HUMAN; KIDNEY INJURY; KIDNEY PERFUSION; KIDNEY TUBULE CELL; KIDNEY TUBULE FUNCTION; LEFT VENTRICULAR ASSIST DEVICE; LETTER; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; BLOOD; FEMALE; KIDNEY; MALE;

CYSTATIN C; FEMALE; HEART FAILURE; HUMANS; KIDNEY; LIPOCALINS; MALE; PROTO-ONCOGENE PROTEINS;

EID: 84922953659     PISSN: 10532498     EISSN: 15573117     Source Type: Journal    
DOI: 10.1016/j.healun.2014.08.021     Document Type: Editorial

References (16)

1. L.H. Lund, J. Matthews, and K. Aaronson Patient selection for left ventricular assist devices Eur J Heart Fail 12 2010 516 520
2. J.N. Cohn, T.B. Levine, and M.T. Olivari Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure N Engl J Med 311 1984 819 823
3. J.M. Brophy, L. Joseph, and J.L. Rouleau Beta-blockers in congestive heart failure. A Bayesian meta-analysis Ann Intern Med 134 2001 550 560
4. C.M. O'Connor, R.C. Starling, and A.F. Hernandez Effect of nesiritide in patients with acute decompensated heart failure N Engl J Med 365 2011 32 43
5. J.J. McMurray, M. Packer, and A.S. Desai Dual angiotensin receptor and neprilysin inhibition as an alternative to angiotensin-converting enzyme inhibition in patients with chronic systolic heart failure: rationale for and design of The Prospective Comparison of ARNI with ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure trial (PARADIGM-HF) Eur J Heart Fail 15 2013 1062 1073
6. Ahmad T, Fiuzat M, Pencina MJ, et al. Charting a roadmap for heart failure biomarker studies. [published online ahead of print June 5, 2014]. JAAC Heart Fail doi: 10.1016/j.jchf.2014.02.005.
7. K.B. Pronschinske, S. Qiu, and C. Wu Neutrophil gelatinase-associated lipocalin and cystatin C for The prediction of clinical events in patients with advanced heart failure and after ventricular assist device placement J Heart Lung Transplant 33 2014 1215 1222
8. E. Braunwald Biomarkers in heart failure N Engl J Med 358 2008 2148 2159
9. L. Kjeldsen, A.H. Johnsen, and H. Sengelov Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase J Biol Chem 268 1993 10425 10432
10. J. Mishra, Q. Ma, and A. Prada Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury J Am Soc Nephrol 14 2003 2534 2543
11. A. Yndestad, L. Landro, and T. Ueland Increased systemic and myocardial expression of neutrophil gelatinase-associated lipocalin in clinical and experimental heart failure Eur Heart J 30 2009 1229 1236
12. E. Singer, L. Marko, and N. Paragas Neutrophil gelatinase-associated lipocalin: pathophysiology and clinical applications Acta Physiol (Oxf) 207 2013 663 672
13. K. Damman, S. Masson, and H.L. Hillege Tubular damage and worsening renal function in chronic heart failure JACC Heart Fail 1 2013 417 424
14. A.S. Maisel, C. Mueller, and R. Fitzgerald Prognostic utility of plasma neutrophil gelatinase-associated lipocalin in patients with acute heart failure: The NGAL EvaLuation Along with B-type NaTriuretic Peptide in acutely decompensated heart failure (GALLANT) trial Eur J Heart Fail 13 2011 846 851
15. V.M. van Deursen, K. Damman, and A.A. Voors Prognostic value of plasma neutrophil gelatinase-associated lipocalin for mortality in patients with heart failure Circ Heart Fail 7 2014 35 42
16. T. Hasin, Y. Topilsky, and J.A. Schirger Changes in renal function after implantation of continuous-flow left ventricular assist devices J Am Coll Cardiol 59 2012 26 36